1. American Society of Clinical Oncology 2010 colorectal update. Issue 9 (September 2010) Authors: Murphy, Janet E; Ryan, David P Journal: Expert review of anticancer therapy Issue: Volume 10:Issue 9(2010) Page Start: 1371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CMET-33. PHASE II STUDY OF PALBOCICLIB IN BRAIN METASTASES HARBORING CDK PATHWAY ALTERATIONS. (11th November 2019) Authors: Brastianos, Priscilla; Cohen, Justine; Wang, Nancy; Lee, Eudocia; Ligibel, Jennifer; Chukwueke, Ugonma; Keeley, Maura; Oh, Kevin; White, Michael; Gerstner, Elizabeth; Batchelor, Tracy; Lawrence, Donald; Ryan, David P; John Iafrate, A; Giobbie-Hurder, Anita; Flaherty, Keith; Santagata, Sandro; Car... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HIPEC for colorectal peritoneal metastases. Issue 2 (February 2021) Authors: Klempner, Samuel J; Ryan, David P Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors. Issue 2 (12th October 2020) Authors: Razak, Albiruni RA; Cleary, James M; Moreno, Victor; Boyer, Michael; Calvo Aller, Emiliano; Edenfield, William; Tie, Jeanne; Harvey, R Donald; Rutten, Annemie; Shah, Manish A; Olszanski, Anthony J; Jäger, Dirk; Lakhani, Nehal; Ryan, David P; Rasmussen, Erik; Juan, Gloria; Wong, Hansen; Soman, Nee... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗